| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Bristol Myers licenses second compound from Prothena | 22 | Seeking Alpha | ||
| Di | Prothena Corporation plc: Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration | 252 | Business Wire | Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target
Prothena... ► Artikel lesen | |
| Di | Bristol Myers Squibb Company: ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries | 557 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Originally published on Bristol Myers Squibb News & PerspectivesGlobally, communities are struggling to support growing healthcare needs. This is especially... ► Artikel lesen | |
| Di | Italy's angels & incubators and venture capital weekly roundup. News from NeoPhore, Bristol Myers Squibb (BMS), Fondo Corporate Partners (FCP), CDP Venture Capital, Angelini Ventures, XGEN, Terna, and more | 17 | BeBeez | ||
| Sa | Women in AI: Sarah Myers West says we should ask, 'Why build AI at all?' | 1 | TechCrunch | ||
| Fr | Bristol Myers Squibb unveils ten-year strategy to improve access to medicines in LMICs | 81 | PMLiVE | ||
| Do | ASCO: Bristol Myers unveils I-O triplet data in melanoma as Iovance touts 'paradigm-changing' combo result | 53 | FiercePharma | ||
| Do | Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms | 477 | Business Wire | Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting... ► Artikel lesen | |
| Do | (BMY) - Analyzing Bristol-Myers Squibb's Short Interest | 49 | Benzinga.com | ||
| 22.05. | Sanofi, Bristol Myers on the hook for $916M in do-over of Plavix marketing case in Hawaii | 64 | FiercePharma | ||
| 22.05. | Bristol Myers, Sanofi liability in Hawaii Plavix litigation tops $900M | 24 | Seeking Alpha | ||
| 22.05. | Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo | 19 | Zacks | ||
| 22.05. | Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M | 13 | Benzinga.com | ||
| 22.05. | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | 24 | Reuters | ||
| 22.05. | Bristol Myers Squibb Company: Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries | 338 | ACCESSWIRE | The Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo in select countries PRINCETON, NJ / ACCESSWIRE /... ► Artikel lesen | |
| 22.05. | Bristol Myers lines up Opdivo treatment in Pakistan, Rwanda and beyond as part of 10-year access campaign | 17 | FiercePharma | ||
| 22.05. | NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb | 255 | PR Newswire | Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionLONDON, May 22, 2024 /PRNewswire/ --... ► Artikel lesen | |
| 21.05. | Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity | 110 | Benzinga.com | ||
| 21.05. | Halozyme: Bristol Myers Gets New PDUFA Date For Subcutaneous Nivolumab Co-Formulated With ENHANZE | 76 | RTTNews | ||
| 21.05. | Bristol-Myers says FDA has revised decision date on injected Opdivo | 120 | Seeking Alpha |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 7.101 |
| NVIDIA | 3.932 |
| EVOTEC | 3.106 |
| GAMESTOP | 2.503 |
| TUI | 2.406 |
| PLUG POWER | 1.730 |
| BAYER | 1.657 |
| VOLKSWAGEN | 1.409 |
| RHEINMETALL | 1.389 |
| AIXTRON SE | 1.247 |
| SUPER MICRO COMPUTER | 1.189 |
| BYD | 1.071 |
| BIONTECH | 1.035 |
| DEUTSCHE LUFTHANSA | 972 |
| SIEMENS ENERGY | 946 |
| RWE | 746 |
| MERCEDES-BENZ | 736 |
| COMMERZBANK | 709 |
| JINKOSOLAR | 708 |
| HELLOFRESH | 702 |
| TESLA | 702 |
| DEUTSCHE BANK | 663 |
| BASF | 616 |
| HEIDELBERGER DRUCK | 605 |
| RENK GROUP | 605 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
